September 2021

Yesterday, I had an odd conversation with a founding team.   They were addressing an important, critical, and an absolutely need-to-solve problem with a lifestyle intervention solution. Lifestyle intervention is an area where I have had a high degree of investment interest. However, the founders' pricing strategy was a significant source of concern for me.   They wanted to address the mass market and, therefore, priced their solution at